Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis | Zendy

Zhenyu Li | Zendy; Ying-li Dong | Zendy; Yun Feng | Zendy; Zhen Zhang | Zendy; Xiaozhong Cao | Zendy

Open Access

Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis

Author(s) -

Zhenyu Li,

Ying-li Dong,

Yun Feng,

Zhen Zhang,

Xiaozhong Cao

Publication year - 2016

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.164701

Subject(s) - reverse transcriptase , telomerase reverse transcriptase , breast cancer , telomerase , medicine , meta analysis , oncology , cancer , cancer research , biology , genetics , polymerase chain reaction , gene

Recently, the relationship between telomerase reverse transcriptase (TERT) polymorphisms and breast cancer risk has been investigated in several publications. However, the results were inconclusive. In this study, we examined the association between TERT polymorphisms and breast cancer risk by meta-analysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research